FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4385843582> ?p ?o ?g. }

• W4385843582 endingPage "e48459" @default.
• W4385843582 startingPage "e48459" @default.
• W4385843582 abstract "Although pre-exposure prophylaxis (PrEP) could substantially mitigate HIV risk, sexual minority men who use stimulants commonly experience difficulties with engaging in PrEP clinical services. Motivational interviewing (MI) and contingency management (CM) reduce substance use and condomless anal sex (CAS) in this population, but these motivational enhancement interventions require modifications to promote engagement along the PrEP care continuum.PrEP Readiness Interventions for Supporting Motivation (PRISM) is a pilot sequential multiple assignment randomized trial testing the feasibility, acceptability, and preliminary effectiveness of distinct combinations of telehealth MI and CM in 70 cisgender sexual minority men who use stimulants that are not currently taking PrEP.A national sample was recruited via social networking applications to complete a baseline assessment and mail-in HIV testing. Those with nonreactive HIV results were randomized to receive either (1) a 2-session MI intervention focusing on PrEP use (session 1) and concomitant stimulant use or CAS (session 2) or (2) a CM intervention with financial incentives for documented evidence of PrEP clinical evaluation by a medical provider (US $50) and filling a PrEP prescription (US $50). At the 3-month follow-up assessment, participants who reported they had not filled a prescription for PrEP were randomized a second time to either (1) switch to a second-stage intervention (ie, MI+CM or CM+MI) or (2) continue with assessments only. Outcomes for both responders and nonresponders were reassessed at a 6-month follow-up. The primary outcome is documented evidence of filling a PrEP prescription over 6 months. Self-reported secondary outcomes include PrEP clinical evaluation by a medical provider, stimulant use, and CAS. Qualitative exit interviews were conducted with a subgroup of responders and nonresponders to characterize their experiences with the MI and CM interventions.Implementation of PRISM underscores challenges in reaching sexual minority men who use stimulants to optimize HIV prevention efforts. Approximately 1 in 10 (104/1060) eligible participants have enrolled. Of the 104 who enrolled, 87 (84%) completed mail-in HIV testing. We delivered 5 preliminary HIV-positive results, including posttest counseling with referrals to confirmatory testing.Lessons learned from PRISM underscore the central importance of a flexible, participant-centered approach to support the engagement of sexual minority men who use stimulants. Leveraging telehealth platforms to deliver motivational enhancement interventions also expanded their reach and potential public health impact with this high-priority population. Further research is needed to determine the effectiveness of telehealth MI and CM for supporting PrEP use in sexual minority men who use stimulants.ClinicalTrials.gov NCT04205487; https://clinicaltrials.gov/study/NCT04205487.DERR1-10.2196/48459." @default.
• W4385843582 created "2023-08-16" @default.
• W4385843582 creator A5002311793 @default.
• W4385843582 creator A5004133608 @default.
• W4385843582 creator A5016640123 @default.
• W4385843582 creator A5017904119 @default.
• W4385843582 creator A5019635523 @default.
• W4385843582 creator A5020233122 @default.
• W4385843582 creator A5034549483 @default.
• W4385843582 creator A5046448683 @default.
• W4385843582 creator A5057846556 @default.
• W4385843582 creator A5059854645 @default.
• W4385843582 creator A5067673432 @default.
• W4385843582 creator A5073059663 @default.
• W4385843582 creator A5080295914 @default.
• W4385843582 date "2023-10-13" @default.
• W4385843582 modified "2023-10-15" @default.
• W4385843582 title "Motivational Enhancement Interventions to Increase Pre-Exposure Prophylaxis Use in Sexual Minority Men Who Use Stimulants: Protocol for a Pilot SMART (Preprint)" @default.
• W4385843582 cites W1607450394 @default.
• W4385843582 cites W1980896885 @default.
• W4385843582 cites W1982624620 @default.
• W4385843582 cites W2013371210 @default.
• W4385843582 cites W2014225025 @default.
• W4385843582 cites W2023455551 @default.
• W4385843582 cites W2026313843 @default.
• W4385843582 cites W2027795129 @default.
• W4385843582 cites W2032449486 @default.
• W4385843582 cites W2042687237 @default.
• W4385843582 cites W2053935709 @default.
• W4385843582 cites W2061214350 @default.
• W4385843582 cites W2065043378 @default.
• W4385843582 cites W2066261281 @default.
• W4385843582 cites W2072930729 @default.
• W4385843582 cites W2074620757 @default.
• W4385843582 cites W2075224529 @default.
• W4385843582 cites W2080857113 @default.
• W4385843582 cites W2085413484 @default.
• W4385843582 cites W2085735325 @default.
• W4385843582 cites W2093186581 @default.
• W4385843582 cites W2095695118 @default.
• W4385843582 cites W2129660502 @default.
• W4385843582 cites W2142893234 @default.
• W4385843582 cites W2149129894 @default.
• W4385843582 cites W2149443374 @default.
• W4385843582 cites W2150104072 @default.
• W4385843582 cites W2163089371 @default.
• W4385843582 cites W2183205588 @default.
• W4385843582 cites W2183228895 @default.
• W4385843582 cites W2236836700 @default.
• W4385843582 cites W2271992345 @default.
• W4385843582 cites W2461496717 @default.
• W4385843582 cites W2555744616 @default.
• W4385843582 cites W2592027212 @default.
• W4385843582 cites W2609613232 @default.
• W4385843582 cites W2621019636 @default.
• W4385843582 cites W2622767954 @default.
• W4385843582 cites W2750964664 @default.
• W4385843582 cites W2791601054 @default.
• W4385843582 cites W2795422796 @default.
• W4385843582 cites W2801892548 @default.
• W4385843582 cites W2805037377 @default.
• W4385843582 cites W2884557556 @default.
• W4385843582 cites W2887041284 @default.
• W4385843582 cites W2897760776 @default.
• W4385843582 cites W2904004728 @default.
• W4385843582 cites W2915339577 @default.
• W4385843582 cites W2940422803 @default.
• W4385843582 cites W2946808384 @default.
• W4385843582 cites W2969299182 @default.
• W4385843582 cites W2973443920 @default.
• W4385843582 cites W2989967436 @default.
• W4385843582 cites W2992342248 @default.
• W4385843582 cites W2994039343 @default.
• W4385843582 cites W2996285144 @default.
• W4385843582 cites W2996602354 @default.
• W4385843582 cites W2996618907 @default.
• W4385843582 cites W2998452976 @default.
• W4385843582 cites W3008938611 @default.
• W4385843582 cites W3031534124 @default.
• W4385843582 cites W3046316787 @default.
• W4385843582 cites W3085807300 @default.
• W4385843582 cites W3103822931 @default.
• W4385843582 cites W3124334260 @default.
• W4385843582 cites W3196427230 @default.
• W4385843582 cites W3216197530 @default.
• W4385843582 cites W3135436225 @default.
• W4385843582 doi "https://doi.org/10.2196/48459" @default.
• W4385843582 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/37831485" @default.
• W4385843582 hasPublicationYear "2023" @default.
• W4385843582 type Work @default.
• W4385843582 citedByCount "0" @default.
• W4385843582 crossrefType "journal-article" @default.
• W4385843582 hasAuthorship W4385843582A5002311793 @default.
• W4385843582 hasAuthorship W4385843582A5004133608 @default.
• W4385843582 hasAuthorship W4385843582A5016640123 @default.
• W4385843582 hasAuthorship W4385843582A5017904119 @default.
• W4385843582 hasAuthorship W4385843582A5019635523 @default.
• W4385843582 hasAuthorship W4385843582A5020233122 @default.

• next